MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide an update on the company activities for the quarter ending 30 September 2023. Highlights: Partnership signed with the Gold Coast Private Hospital (a member of Healthscope), to establish a Precision Medicine Clinic at the hospital.GeneType Multi-Test
Emma was diagnosed with post-natal depression after a traumatic birth experience. She says the help she got from a specialised mother and baby unit saved her life and now she's worried for other mothers because the unit is closing.
The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
A secret wish of many DIY investors is to get an unbiased second opinion on their portfolio.
In a hot stock market like we have now, we’re all genius investors. But realists know the test of smart do-it-yourself investing is to consistently generate the returns you need over long periods of time. If you have doubts about that, a second opinion makes sense.